# FDA Inspection 1204017 - Aldeyra Therapeutics, Inc. - April 28, 2023

Source: https://www.keypedia.com/records/fda_inspections/aldeyra-therapeutics-inc/b05797b9-b4be-468a-9213-c72e5207bfdf
Source feed: FDA_Inspections

> FDA Inspection 1204017 for Aldeyra Therapeutics, Inc. on April 28, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204017
- Company Name: Aldeyra Therapeutics, Inc.
- Inspection Date: 2023-04-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/aldeyra-therapeutics-inc/1a871130-ca82-4441-a7a4-7d7c28561ffa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c